Hyundai Motor India: Street targets ₹2,475 in 2026

Why Hyundai Motor India is in focus

Hyundai Motor India shares drew strong brokerage attention after the company reported results for the quarter and year ended March 31, 2026. On Monday, May 11, the stock rallied as much as 5% to an intraday high of ₹1,944 on the NSE, even as multiple reports flagged a softer quarterly profit print. Investor sentiment was also helped by rating actions from domestic brokerages, including an upgrade from HDFC Securities and a reiterated view from JM Financial.

A separate update later in the cycle also kept the stock in focus. On June 11, 2026, reports said Hyundai Motor India shares were up 2% after a key update linked to a disruption at its Chennai plant. The combination of earnings commentary, guidance for FY27, and product pipeline disclosures has shaped the current debate on valuation and growth visibility.

Q4 FY26 results: profit fell, revenue grew for FY26

The company reported a 22% drop in net profit to ₹1,256 crore for Q4 FY26, compared with ₹1,614 crore in the year-ago period. Despite the quarterly hit, the full-year topline showed modest growth.

For FY26, Hyundai Motor India reported a 2% year-on-year rise in revenue to ₹70,763 crore. Net profit for FY26 declined 4% year-on-year to ₹5,543 crore versus FY25. These numbers framed brokerage takes that leaned on upcoming launches, potential market share recovery, and the company’s export positioning.

FY27 outlook: volume growth guidance and margin band

Management guidance and brokerage notes highlighted a consistent growth target for both domestic and exports. Hyundai expects domestic volume growth of 8–10%, driven by product actions and network expansion. It also guided for export volume growth of 8–10%, supported by market diversification and product-led opportunities.

Hyundai has also set an EBITDA margin guidance range of 11–14%. Broker commentary cited in reports said margins were seen to have bottomed out, even as Q4 EBITDA came in below expectations for at least one brokerage.

Product pipeline: planned launches and SUV triggers

Brokerages focused heavily on the product cycle. Analysts at Nomura said two upcoming SUV launches are likely to support above-industry growth of 8–10% in FY27F. Nomura also projected a domestic volume CAGR of 13% over FY26–FY28, driven by a new model cycle.

Nomura’s note also pointed to improved disclosures around the model pipeline and export guidance as likely positives for the market. The brokerage referred to 26 planned launches through FY30, which has become a core plank for the growth narrative shared by multiple analysts.

Capex plan: ₹7,500 crore for India growth

The company plans a capital expenditure of around ₹7,500 crore to support its growth in India, as cited in the reports. Capex plans were discussed alongside network expansion and product actions, suggesting management is positioning for a broader push across demand pockets.

The guidance also referenced profitability discipline, with the EBITDA margin range of 11–14% serving as a key datapoint for investors tracking cost pressures and mix improvements.

CEO commentary: April volumes and export watch

Following the earnings, Managing Director and CEO Tarun Garg said the company had started FY27 on a strong footing, with April domestic volumes growing 17% year-on-year. He said Hyundai expects the momentum to continue and reiterated the expectation of 8–10% domestic volume growth, backed by new product launches in high-demand segments and other strategic initiatives.

Garg also said the company remains watchful of geopolitical uncertainties in exports, but is confident of achieving 8–10% export volume growth and reinforcing its position as a hub for emerging markets.

Dividend: board recommends ₹21 per share

Along with the earnings, the board recommended a final dividend of ₹21 per equity share (face value ₹10 each) for the financial year ended March 31, 2026. The dividend is subject to shareholder approval at the upcoming 107th AGM.

For income-focused investors, this announcement added a second track to the story beyond volumes and product cadence.

Brokerage calls and targets: upgrades, reiterations, and highs

Brokerage views in the reports spanned a wide range of targets.

• ICICI Securities carried a “Buy” call with a target of ₹2,475, against a recommendation price of ₹1,975.70.
• Nomura maintained “Buy” but cut its target price to ₹2,407 from ₹2,698.
• HDFC Securities upgraded the stock to “Add” with a target price of ₹2,103.
• JM Financial reiterated “Add” with a target price of ₹1,950, valuing the company at 23x FY28E EPS.
• Motilal Oswal Financial Services maintained “Buy” with a target price of ₹2,160.
• UBS initiated coverage with a “Buy” rating and a target price of ₹2,350.
• Goldman Sachs initiated coverage with a “Buy” rating and a target price of ₹2,600, indicating a potential 21% upside from Monday’s close, as cited.

Separately, a market snapshot cited an average 12-month price target of ₹2,207.08, with a high estimate of ₹2,475 and a low estimate of ₹1,600. The same snapshot said 22 analysts recommend buying the stock while two suggest selling.

Stock move and recent performance snapshots

On May 11, the stock hit an intraday high of ₹1,944, before paring gains. At 1:00 PM that day, it traded at ₹1,908.90, up 3.03% from the previous close of ₹1,852.80. Another data point in the same collection said at 12:35 PM Hyundai Motor India shares were trading at ₹1,910.1, rising 3.09%.

Performance snapshots in the reports varied by reference period and data source. One report said the stock gained 9% over a month but fell 19% over the last six months. Another noted shares were still down more than 18% so far in 2026. Separate market tracker lines cited the stock at ₹1,992.00 as of July 13, 2026, and also included different year-to-date percentage references.

Key numbers at a glance

Market impact: what investors are tracking

The immediate market reaction reflects a balancing of weaker Q4 profitability with forward guidance and product-cycle visibility. The stock’s sharp move on May 11 came alongside brokerage commentary that focused on launches, network expansion and potential market share recovery rather than a single quarter’s earnings.

On the fundamentals, investors have clear datapoints to monitor: domestic and export growth guidance of 8–10%, the 11–14% EBITDA margin band, and the ₹7,500 crore capex plan. The dividend recommendation of ₹21 per share, pending shareholder approval, adds another measurable event for the near-term calendar.

Analysis: why the product cycle and guidance matter

Brokerage notes broadly tied the outlook to a new model cycle and a defined launch pipeline, including 26 planned launches through FY30 as cited by Nomura. In that context, guidance becomes more than a headline range, because it sets the base case against which each launch and distribution expansion will be judged.

The range of price targets also shows what the market is debating: how quickly Hyundai can regain market share, sustain exports amid geopolitical uncertainty, and hold margins within the guided band. Differing brokerage stances, from “Add” to “Buy,” reflect varying comfort levels on execution and the durability of demand.

Conclusion

Hyundai Motor India’s post-results rally highlights investor focus on FY27 guidance, planned launches, and a ₹7,500 crore capex roadmap, even as Q4 FY26 net profit fell to ₹1,256 crore. The next set of milestones includes shareholder approval of the ₹21 final dividend at the 107th AGM and further updates tied to launches and operational continuity, including developments around the Chennai plant disruption referenced in June.